Determining the gastrointestinal nemabiome of sheep and goats in the USA

Active Cooperative Agreement Awarded

Award ID
U18FD008947
Recipient
Awarding agency
Obligated
$136,014

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date 8% complete
Funding agency
Food and Drug Administration Department of Health and Human Services
Place of performance
Ithaca, NY, USA

Award details come from USAspending.gov.

About this award

The U.S. Department of Health and Human Services Food and Drug Administration awarded Cornell University a Cooperative Agreement, U18FD008947, totaling $136,014 on September 23, 2026, under Assistance Listing 93.103, Food and Drug Administration Research. The Office of Sponsored Programs is the awardee division. The program assists institutions and organizations to establish, expand, and improve research, demonstration, education and information dissemination activities.

The project will determine the gastrointestinal nemabiome of sheep and goats in the United States. Cornell will analyze 1,800 fecal samples from sheep and goats across nine states: New York, North Carolina, Georgia, Michigan, Indiana, Wisconsin, Wyoming, Texas, and Washington. The work applies deep amplicon sequencing on Oxford Nanopore Technologies' MinION device, combined with a bioinformatics pipeline, to identify nematode species from ITS-2 DNA markers extracted from feces. Each participating state's accredited diagnostic laboratory, affiliated with the American Association of Veterinary Laboratory Diagnosticians, will assist in collecting samples. Sample collection occupies 18 months of a 24-month project. The ultimate completion date is August 31, 2028, and the place of performance is Ithaca, NY.

Description

Abstract
Parasitic diseases in sheep and goats caused by gastrointestinal (GI) nematodes, often called strongyles, lead to significant economic losses to producers in the US. Over 20 strongyle species infect these animals, often in mixed infections. Some are highly pathogenic. Together, they form the GI nemabiome, and understanding its composition helps optimize treatment strategies and evaluate their effectiveness. While the nemabiome is known to impair ruminant health and cause major production losses-primarily due to pathogenic species-its potential beneficial roles in production systems remain underexplored. Traditional parasitological methods for identifying the nemabiome in ruminants have limitations, which molecular techniques, such as PCR and DNA marker sequencing (e.g., its-2), aim to overcome. This process involves extracting DNA from nematodes in animal feces, amplifying IT with universal primers targeting conserved regions flanking the variable its-2 segment, and sequencing the PCR products. These sequences are compared against a database of GI nematode its-2 sequences to identify species. The ahdc parasitology lab has developed and validated a deep amplicon sequencing method using oxford nanopore technologies' minion device, supported by the federal capacity funds (hatch grant). The minion offers a more cost-effective alternative to the illumina miseq for routine diagnostic purposes. We will analyze 1,800 fecal samples from sheep and goats across nine U.S. States-new york, north carolina, georgia, michigan, indiana, wisconsin, wyoming, texas, and washington-using this platform and our bioinformatics pipeline. The project spans 24 months, with 18 months dedicated to sample collection. Each participating state's accredited diagnostic laboratory, affiliated with the american association of veterinary laboratory diagnosticians (AAVLD), will assist in collecting samples. The main goals are: 1) to gain a detailed understanding of the nemabiome of small ruminants across these states in the US, and 2) to streamline the workflow and pipeline for rapid, affordable sequencing of the nemabiome, making this capacity accessible to other veterinary diagnostic labs and providing this service to benefit the small ruminant production industry in the US.

Quick answers

Who received award U18FD008947?

U18FD008947 was awarded to Cornell University by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 23, 2026.

How much is award U18FD008947 worth?

$136,014 has been obligated on U18FD008947.

Which agency awarded U18FD008947?

FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U18FD008947, with funding from Food and Drug Administration (Department of Health and Human Services).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award